Evidence map›Paper›PMID 29191945›Full record

ArticleEMBO molecular medicine2018

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim.

Alessandro Pecci, Iman Ragab, Valeria Bozzi, Daniela De Rocco, Serena Barozzi, Tania Giangregorio, Heba Ali, Federica Melazzini, Mohamed Sallam, Caterina Alfano and 3 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Journal of genetics · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Alessandro PecciDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Iman RagabHematology-Oncology Unit, Pediatric Hospital, Ain Shams University, Cairo, Egypt.
Valeria BozziDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Daniela De RoccoInstitute for Maternal and Child Health - IRCCS Burlo Garofolo, Trieste, Italy.
Serena BarozziDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Tania GiangregorioDepartment of Medical Sciences, University of Trieste, Trieste, Italy.
Heba AliHematology-Oncology Unit, Pediatric Hospital, Ain Shams University, Cairo, Egypt.
Federica MelazziniDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Mohamed SallamDepartment of Clinical Pathology, Ain Shams University, Cairo, Egypt.
Caterina AlfanoMaurice Wohl Clinical Neuroscience Institute, King's College, London, UK.
Annalisa PastoreDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Carlo L BalduiniDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Anna SavoiaInstitute for Maternal and Child Health - IRCCS Burlo Garofolo, Trieste, Italy anna.savoia@burlo.trieste.it.ORCID 0000-0002-2407-2696
University of Pavia · ITAin Shams University Hospital · EGUniversity of Trieste · ITAin Shams University · EGIRCCS Materno Infantile Burlo Garofolo · ITKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital amegakaryocytic thrombocytopenia (CAMT) is an inherited disorder characterized at birth by thrombocytopenia with reduced megakaryocytes, which evolves into generalized bone marrow aplasia during childhood. Although CAMT is genetically heterogeneous, mutations of

Indexed as

Point MutationCell LineChild, PreschoolCongenital Bone Marrow Failure SyndromesFemaleHEK293 CellsHumansInfantMalePedigreeReceptors, FcReceptors, ThrombopoietinRecombinant Fusion ProteinsThrombocytopeniaThrombopoietinMPL protein, humanReceptors, FcReceptors, ThrombopoietinRecombinant Fusion ProteinsromiplostimThrombopoietincongenital amegakaryocytic thrombocytopeniaMPLmutationromiplostimthrombopoietin

Identifiers

PMID29191945
PMCPMC5760853
OpenAlexW2773907837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.